DFNS · XBRL financial data
T3 Defense financial statements, every quarter
The same tables from 14 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (DFNS's year ends in late December)
- † Share count changed about 8x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/36 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal quarters (DFNS's year ends in late December)
- † Share count changed about 8x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/36 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal quarters (DFNS's year ends in late December)
| In thousands of dollars | Sep 30, 2023 | †Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | †Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (126) | (8,928) | (2,429) | (1,616) | 4,455 | (160,788) | 102,958 | 3,019 | (16,365) | (11,062)* | (27,147) | (81,430) |
| Stock-based compensation | 75* | 2,090 | 75 | 75* | 6* | 6 | 178 | 0* | 0* | 18,648* | 1,907 | 0* |
| Depreciation and amortization | year only | — | — | — | — | — | — | — | — | — | — | — |
| Net cash from operating activities | (121)* | (738) | (1,123) | (698)* | (1,392)* | (340) | (1,342) | (1,352)* | (2,506)* | (999)* | (4,927) | (4,864)* |
| Purchases of property and equipment | — | — | — | — | — | — | 10 | 5* | 4* | 12* | 154 | 26* |
| Net cash from investing activities | (914)* | 130 | 1* | 0* | 1* | (936) | (810) | (705)* | (2,004)* | (176,308)* | (3,823) | (620)* |
| Proceeds from issuing common stock | — | — | — | — | — | 478 | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | 297 | — |
| Net cash from financing activities | 132* | 746 | 921 | 585* | 881* | 9,063 | — | — | 9,225* | 173,638* | 12,476 | 2,877* |
| Net change in cash | (1,163)* | 172 | (212) | (112)* | (503)* | 7,823 | (2,119) | (2,865)* | 4,738* | (3,665)* | 3,726 | (2,607)* |
- † Share count changed about 8x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/36 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| T3 Defense | 4,085 | 3,996 | (4,864)* | 1.7M | 1.3 quarters | 10-QJun 30, 2026 |
| GenFlat Holdings | 2,464 | 0* | (1,498)* | 13.1M | 1.6 quarters | 10-KJun 30, 2026 |
| ACCESS Newswire | 2,962 | 5,618 | 173* | 3.8M | — | 10-QJun 30, 2026 |
| CISO Global | 722 | 5,791 | (69)* | 45.5M | 10.5 quarters | 10-QJun 30, 2026 |
| Mastech Digital | 37,939 | 41,987 | 2,648* | 12.0M | — | 10-QSep 30, 2026 |
| Nordicus Partners | 5.8 | not reported | (160) | 19.4M | 0.0 quarters | 10-QJun 30, 2026 |
| Castellum | 16,865 | 13,865 | 1,060* | 94.8M | — | 10-QJun 30, 2026 |
| Pharma-Bio Serv | 1,518 | 2,336 | 61 | 22.9M | — | 10-QJul 31, 2026 |
| Panamera Holdings | 0 | 0 | (45)* | 79.9M | 0.0 quarters | 10-QApr 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.